13F filer · CIK 1179392 ↗
Two Sigma
You are looking at Q4 2016. See the latest, Q2 2026 →
Reported value
$26.08B
−5.5% on the quarter before
Positions
3,021
742 new · 770 sold out
Top 10
6.6%
of the value
Est. gain
+$292.3M
on stocks held all quarter
Est. return
+2.4%
on those stocks since Q3 2016
Positions as of Dec 31, 2016, from Two Sigma's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 15% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2016. Striped tiles are options.
Largest buys
Since Q3 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Micron~$165.4MNew · 0.0% → 0.6%+7,547,563 shares
- Medtronic Plc~$161.7MAdded · 0.0% → 0.7%+2,270,432 shares
- Biogen Inc~$151.9MAdded · 0.0% → 0.6%+535,631 shares
- Netflix~$141.0MAdded · 0.0% → 0.6%+1,139,207 shares
- Hewlett Packard Enterprise~$139.1MAdded · 0.1% → 0.6%+6,013,394 shares
- Lowes Cos Inc~$115.9MAdded · 0.1% → 0.6%+1,630,274 shares
- Seagate Technology Plc~$102.6MAdded · 0.0% → 0.4%+2,687,797 shares
- Aetna Inc New~$98.7MAdded · 0.3% → 0.7%+795,565 shares
- S&P Global Inc~$94.6MAdded · 0.1% → 0.5%+879,728 shares
- Nxp Semiconductors N V~$93.3MAdded · 0.0% → 0.4%+952,364 shares
Largest sells
Since Q3 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Marriott Intl Inc New~$248.7MCut · 0.7% → 0.0%−3,007,953 shares
- Wells Fargo & Co New~$199.4MCut · 0.6% → 0.1%−3,618,968 shares
- Amazon~$197.0MSold out · 0.7% → 0.0%−235,321 shares
- Celgene Corp~$195.7MCut · 0.6% → 0.0%−1,692,973 shares
- Verizon Communications Inc~$181.3MCut · 0.6% → 0.0%−3,397,419 shares
- Alphabet~$180.8MSold out · 0.7% → 0.0%−224,811 shares
- Kroger Co~$178.3MCut · 0.6% → 0.0%−5,165,865 shares
- Wal-Mart Stores Inc~$178.2MCut · 0.7% → 0.0%−2,578,214 shares
- Applied Materials~$167.0MCut · 0.6% → 0.0%−5,175,669 shares
- Coca Cola Co~$150.4MSold out · 0.5% → 0.0%−3,553,519 shares
Holdings
As of Dec 31, 2016. Changes are in shares against Sep 30, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aetna Inc NewCOM · shares +110% · price +7.4% | 0.72% | $188.0M | +$6.2M | ||||||||
| Dow Chem CoCOM · shares −15% · price +10.4% | 0.70% | $182.6M | +$17.2M | ||||||||
| Du Pont E I De Nemours & CoCOM · shares −15% · price +9.6% | 0.68% | $177.8M | +$15.6M | ||||||||
| Humana IncCOM · shares +22% · price +15.3% | 0.68% | $177.2M | +$19.4M | ||||||||
| Gilead Sciences IncCOM · shares +20% · price −9.5% | 0.65% | $170.8M | −$14.9M | ||||||||
| Medtronic PlcSHS · shares +1,815% · price −17.6% | 0.65% | $170.6M | −$1.9M | ||||||||
| CiscoCOM · shares +117% · price −4.7% | 0.65% | $168.8M | −$3.9M | ||||||||
| MicronCOM · shares New | 0.63% | $165.4M | — | ||||||||
| Anthem IncCOM · shares +23% · price +14.7% | 0.63% | $165.4M | +$17.3M | ||||||||
| Biogen IncCOM · shares +1,930% · price −9.4% | 0.61% | $159.8M | −$817,109 | ||||||||
| Monsanto Co NewCOM · shares +33% · price +2.9% | 0.61% | $159.5M | +$3.4M | ||||||||
| Hewlett Packard EnterpriseCOM · shares +863% · price +1.7% | 0.60% | $155.3M | +$272,255 | ||||||||
| Lockheed Martin CorpCOM · shares −12% · price +4.3% | 0.59% | $155.1M | +$6.3M | ||||||||
| Colgate Palmolive CoCOM · shares +56% · price −11.7% | 0.59% | $153.3M | −$13.1M | ||||||||
| Cigna CorporationCOM · shares −0.6% · price +2.4% | 0.59% | $153.2M | +$3.5M | ||||||||
| NetflixCOM · shares +1,447% · price +25.6% | 0.58% | $150.8M | +$2.0M | ||||||||
| Baxter Intl IncCOM · shares +11% · price −6.8% | 0.57% | $149.9M | −$9.9M | ||||||||
| Home Depot IncCOM · shares −24% · price +4.2% | 0.57% | $148.4M | +$6.0M | ||||||||
| Lowes Cos IncCOM · shares +369% · price −1.5% | 0.57% | $147.4M | −$481,457 | ||||||||
| Teva Pharmaceutical Inds LtdADR · shares +53% · price −21.2% | 0.54% | $142.1M | −$25.0M | ||||||||
| Abbott LabsCOM · shares +57% · price −9.2% | 0.54% | $141.8M | −$9.1M | ||||||||
| St Jude Med IncCOM · shares +5.7% · price +0.5% | 0.54% | $141.7M | +$718,821 | ||||||||
| Vmware IncCL A COM · shares −20% · price +7.3% | 0.54% | $139.8M | +$9.6M | ||||||||
| KLACOM · shares +27% · price +12.9% | 0.53% | $138.3M | +$12.4M | ||||||||
| Yahoo IncCOM · shares +43% · price −10.3% | 0.52% | $136.4M | −$10.9M | ||||||||
| Total · 3,021 positions | 100% | $26.08B | +$292.3M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2016 to Q4 2016: 1,570 stocks held throughout, up $292.3M (+2.4%).
- United States Stl Corp New+$32.7M+75%
- Humana Inc+$19.4M+15%
- AMD+$18.1M+64%
- Anthem Inc+$17.3M+15%
- Dow Chem Co+$17.2M+10%
- Sina Corp−$12.4M−18%
- Colgate Palmolive Co−$13.1M−12%
- Vodafone Group Plc New−$14.0M−16%
- Gilead Sciences Inc−$14.9M−9%
- Teva Pharmaceutical Inds Ltd−$25.0M−21%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 7 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $138.12B+11% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $123.93B+75% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $70.90B+6% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $67.17B+19% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $56.47B+21% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $46.79B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $45.85B+0% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $45.63B+4% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $43.90B+3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $42.61B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $43.54B+17% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $37.17B−7% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $39.87B+14% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $34.99B+10% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $31.85B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $29.43B−3% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $30.30B−11% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $33.88B−28% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $46.81B+5% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $44.75B+1% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $44.08B+15% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $38.44B+10% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $34.85B+24% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $28.17B+40% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $20.19B+64% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $12.28B−63% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $33.24B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $29.72B−1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $29.90B−3% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $30.85B+21% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $25.54B−30% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $36.69B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $33.54B+12% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $30.04B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $30.72B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $28.21B+2% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $27.64B−7% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $29.70B+14% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $26.08B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $27.59B+18% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.29B+11% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $20.99B | SEC ↗ |